Page 35 - Read Online
P. 35

Gasparello et al. J Cancer Metastasis Treat 2019;5:52  I  http://dx.doi.org/10.20517/2394-4722.2019.17                      Page 3 of 11

                  A                                                 B



















               Figure 1. Flow chart describing the experimental in vivo model system. All the procedures have been performed according to Directive
               2010/63/EU and Italian Decree Law 26/2014. They were approved by the EU Research Executive Agency, the Intramural Regina Elena
               Board for Animal Welfare, and the Italian Ministry of Health (700-2015-PR, dated July 17, 2015). Tumor xenotransplants were established
                             6
               by inoculating 3 × 10  cells from the HT-29 and LoVo cell lines in the flank of 4-month old Nu/CD1 mice (Charles River Laboratories, Italy).
                                                                    3
               Xenotransplants were allowed to grow to two different sizes (300 and 1000 mm , 6 mice per group for each of the two cell lines). Tumors
               were taken at sacrifice along with blood. Frozen tissues were used as the source of miRNAs. Blood was collected in 6 mL BD Vacutainer
               K2E tubes (BD, 368857) and centrifuged within 1 h at 2000 ×g for 20 min at 4 °C. Plasma was recovered and further centrifuged at
               16,000 ×g for 10 min at 4 °C to remove cell debris, and stored at -80 °C until extraction

               Table 1. Technologies applied to miRNA detection
                Technologies  Biological fluid                Major results obtained                 Ref.
                Real-time        Plasma    RNA was isolated from human plasma samples of healthy donor and the content of   [52]
                quantitative PCR           three miRNAs chosen to represent moderate- to low-abundance plasma miRNAs
                                           (miR-15b, miR-16, and miR-24) was evaluated using TaqMan RT-qPCR assays
                NGS RNA          Serum     A NGS RNA sequencing (Solexa sequencing) approach, followed by RT-qPCR data   [53]
                sequencing                 validation was employed to identify miRNAs able to predict prognosis of non-
                                           small-cell lung cancer. Four miRNAs (miR-486, miR-30d, miR-1 and miR-499) were
                                           significantly associated with overall survival
                MicroRNA         Serum     A global miRNA profiling was performed, using GeneChip miRNA Arrays   [54]
                microarray analysis        (Affymetrix) in prostate adenocarcinoma transgenic mouse models identifying 46
                                           miRNAs significantly altered compared to healthy controls
                Droplet digital PCR  Plasma  Droplet digital PCR platform was used to assess  levels of miRNAs (miR-221, miR-  [55]
                                           222 and miR-141) released into the culture supernatants of colorectal carcinoma
                                           cell lines and mouse blood plasma obtained  from xenograft models
                MicroRNA low     Plasma    Circulating miRNAs profile was examined in mice bearing human small cell lung   [56]
                Density Arrays             cancer tumor xenografts using  human TaqMan Low Density Array
                                           The analysis allows to identify a panel of differentially expressed miRNAs, in a
                                           stage dependent manner
                Rolling circle   Serum     The rolling circle amplification of a universal adapter sequence selectively ligated   [57]
                amplification              to targets captured on encoded gel microparticles is employed for multiplexed
                                           profiling of miRNAs at sub-femtomolar concentration. The protocol was optimized
                                           to cover a dynamic range of magnitude (300 aM to 40  pM). Moreover, miRNAs
                                           can be directly detected in small quantities of unprocessed serum samples
                                           avoiding RNA extraction or target-amplification steps
                Isothermal       Plasma    Isothermal RAM allows the direct amplification of miRNAs without upstream   [58]
                ramification               sample preparation. The presence of microRNA promotes base-stacking
                amplification              hybridization, and subsequent amplification between two universal strands, under
                (RAM)                      isothermal conditions. A sensitivity in the range of femtomolar is provided
                Northern blotting  Tissues  An highly efficient microRNAs detection method based on northern blot analysis   [59]
                                           was set-up using LNA (locked nucleic acid) probes able to increase the sensitivity
                                           of at least 10-fold compared  to conventional DNA probes
                Bead-based flow   Tissue/cell lines  Oligonucleotide-capture probes complementary to miRNAs of interest were   [60]
                Cytometry                  coupled to carboxylated 5- micron polystyrene Beads impregnated with variable
                                           mixtures of two fluorescent dyes each representing a single miRNA
                                           After the reverse transcription miRNAs are amplified by polymerase chain reaction
                                           and hybridized to the capture beads, beads were then analysed using a flow
                                           cytometer capable of measuring bead colour
   30   31   32   33   34   35   36   37   38   39   40